Alpha Tau Medical ltd   (DRTS)
Other Ticker:  


Alpha Tau Medical ltd

DRTS's Financial Statements and Analysis

Alpha Tau Medical ltd narrowed IV. Quarter net loss per share of $-0.53 compare to net loss per share of $-0.67 recorded in the same quarter a year ago a decrease compare to $0.00 realized in previous quarter.

IV. Quarter
Earnings Per Share Revenues
$ -0.53 $  0 Mill
$+0.14     Unch.    

Alpha Tau Medical Ltd 's Revenue fell by 0 % in IV. Quarter (Dec 31 2022) year on year, to $0 million and declined by sequentially.

Alpha Tau Medical Ltd is Expected to report next financial results on March 08, 2024.

More on DRTS's Income Statement

Alpha Tau Medical Ltd 's net income of $33.762 million in IV. Quarter increased by 23.8 % from net earnings of $27.271 million achieved in IV. Quarter a year ago.

Sequentially Company turn into Profitability from net loss of $0.000 million recorded in previous quarter.

More on DRTS's Growth

Alpha Tau Medical Ltd Inventories
In IV. Quarter company's net cash and cash equivalents decreased by $-17 million, capital expenditures grew by -69.12%, to $-1 millions compare to same quarter a year ago and fell by